Возраст домена | 25 лет |
Дата окончания | Через 6 месяцев |
PR | 6 |
ИКС | |
Страниц в Google | 269 |
Страниц в Яндексе | 104 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 3670863 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Pharmaceutical News And Information - InternetDrugNews.com
Pharmaceutical News And Information
Pharmaceutical News And Information Updated Daily Since 1998
WINDOWS-1252
73.78 КБ
2 500
32 129 симв.
26 707 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
accessrx.com | 355 | 4 |
10 | 388287 | 123957 | |
charm.com | 256 | 5 |
10 | 1232484 | Нет данных | |
jillsgenealogy.com | 231 | 3 |
0 | Нет данных | Нет данных | |
bellwoodlibrary.org | 205 | 4 |
0 | 13200823 | Нет данных | |
socgeografialisboa.pt | 203 | 6 |
0 | 2320762 | Нет данных | |
hotcanadianpharmacy.com | 196 | n/a | 0 | 1015593 | Нет данных | |
cialis.com | 195 | 4 |
40 | 1198780 | Нет данных | |
mseyes.com | 145 | 5 |
0 | 11574911 | Нет данных | |
ywcanh.org | 141 | 4 |
0 | 5502058 | Нет данных | |
mens-health-meds.net | 118 | n/a | 0 | 6835466 | Нет данных | |
247medication.com | 4 | 2 |
0 | Нет данных | Нет данных | |
8m.com | 1 | 7 |
0 | 9118717 | Нет данных | |
8k.com | 1 | 7 |
160 | 8961098 | Нет данных | |
7xjung.de | 1 | 4 |
0 | 14715242 | Нет данных | |
50megs.com | 1 | 6 |
0 | 85233 | 24022 | |
22design.co.uk | 1 | n/a | 0 | 12796298 | Нет данных | |
180360720.no | 1 | 4 |
0 | 6866198 | Нет данных | |
12south.org | 1 | 3 |
0 | 12668147 | Нет данных | |
0to5.com | 1 | 3 |
0 | 2396194 | 510233 | |
00it.com | 1 | 4 |
0 | 1202023 | 9035 | |
Еще 30 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
StatCounter | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 11 Ноября 2016 ) | |
Количество ссылок на сайт | 29351 |
Количество доменов, которые ссылаются на сайт | 254 |
Количество найденных анкоров | 165 |
Исходящие (внешние) ссылки домена | 2122 |
Количество доменов, на которые ссылается сайт | 572 |
Количество исходящих анкоров | 698 |
Внешние ссылки главной страницы ( 144 ) | |
medilexicon.com/medicaldictionary.php | Medical Dictionary |
clinicaltrials.gov/ct2/home | Clinical Trial Results |
ncbi.nlm.nih.gov/sites/entrez/ | SEARCH Medline |
nlm.nih.gov/medlineplus/ | Medline Plus |
amedeo.com/index.htm | Amedeo |
fda.gov/cder/approval/index.htm | CDER LIst |
fda.gov/cder/drug/DrugSafety/DrugIndex.htm | Boiler Plate Patient Info |
fda.gov/AdvisoryCommittees/Calendar/default.htm | Advisory Documents |
centerwatch.com/clinical-trials/listings/ | Database Of Ongoing Clinical Trials |
newdrugapprovals.org/ | New Drug Approvals.org |
fda.gov/Drugs/DrugSafety/ucm199082.htm | Dear Doctor Letter Database |
accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseact... | Drugs@FDA |
accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseact... | Newly filed ANDA's |
accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseact... | Product Data Database |
accessdata.fda.gov/scripts/cder/ob/default.cfm | Orange Book |
centerwatch.com/drug-information/fda-approvals/ | Recently Approved Drugs (CenterWatch) |
fda.gov/opacom/hpmeetings.html | Upcoming Meetings |
fda.gov/medwatch/safety.htm | Medwatch |
fda.gov/opacom/7alerts.html | Recalls/Alerts |
fda.gov/Drugs/InformationOnDrugs/ucm142438.htm | NDC Code Directory |
fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforP... | Postmarketing Safety Data |
fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Enforc... | Warning Letters |
medilexicon.com/ | - |
hon.ch/HONcode/Conduct.html?HONConduct337777 | verify here |
hon.ch/HONcode/Conduct.html | HONcode standard for trustworthy health |
pharmagossip.blogspot.com/ | - PharmaGossip |
patentdocs.org/ | - Patent Docs |
mmm-online.com// | - Medical Media & Marketing News |
blog.farmazia.net/// | - Farmazia.Net (Spain) |
canadapharmacynews.com/ | - Canada Pharmacy News |
newhopeblog.com/ | - NewHopeBlog.com |
drugwonks.com/ | - Drug Wonks |
worldofdtcmarketing.com/ | - World Of DTC Marketing.com |
reuters.com/article/us-shire-m-a-takeda-pharma/hopes-rise-fo... | Hopes rise for Shire sale as Takeda CEO discusses case for deal |
endpts.com/21b-or-bust-abbvie-ensures-its-blockbuster-us-mar... | 21B or bust! AbbVie ensures its blockbuster US marathon on Humira will run into 2023 |
statnews.com/pharmalot/2018/04/05/trump-patents-muscular-dys... | Trump administration is urged to override patents on pricey muscular dystrophy drug |
lundbeck.com/upload/global/files/pdf/features/ENGLISH%2520-%... | 'Corporate Reputation of Pharma in 2017-- the Patient Perspective' |
thetimes.co.uk/article/20m-secret-payments-to-plug-drugs-by-... | 20m 'secret payments' to plug drugs by Astrazeneca and Shire |
endpts.com/riding-a-wave-of-positive-phiii-readouts-pfizer-g... | Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib |
finance.yahoo.com/news/lillys-cyramza-succeeds-stage-liver-1... | Lilly's Cyramza succeeds in late-stage liver cancer trial |
statnews.com/2018/04/02/justice-department-opioids-lawsuits/ | Justice Dept. says it will seek to join settlement talks in opioid lawsuits |
libn.com/2018/04/03/rosenberg-could-henry-schein-be-a-target... | Rosenberg: Could Henry Schein be a target of Amazon's ambition? |
fiercepharma.com/marketing/amgen-switches-up-repatha-tv-ads-... | Amgen darkens the mood in new Repatha TV ads, warning of heart and stroke risks |
repathahcp.com/?&WT.z_co=A&WT.z_in=DYS&WT.z_ch=PDS&WT.z_st=S... | prevents heart attacks and stroke |
mprnews.org/story/2018/03/30/penny-a-pill-funding-fades-unde... | 'Penny-a-pill' funding fades under pressure from pharmaceutical industry |
globaltimes.cn/content/1096505.shtml | Swiss drugmaker Novartis faces bribery allegations in China |
fool.com/investing/2018/04/04/which-big-pharma-ceos-least-de... | Which Big Pharma CEOs Least Deserved Their Big Pay Increases? |
bloomberg.com/news/articles/2018-04-03/trump-tariffs-target-... | Trump Tariffs Target Key Ingredients for Dozens of Drug |
finance.yahoo.com/m/f6a44d1c-1b2d-34cd-be39-803794c5f0c9/j%2... | J&J Jury Set to Weigh Banker's Claims Baby Powder Caused Cancer |
cafepharma.com/cpwire/article/Eisai-Submits-Supplemental-New... | Eisai Submits to FDA for FYCOMPA (perampanel) Pediatric Indications |
huffingtonpost.com/entry/martin-shkreli-aids-drug-price-the-... | Yep, Martin Shkreli's 5,000 Percent Drug Price Hike Is Still In Effect |
barrons.com/articles/buyout-target-express-scripts-has-30-pl... | Buyout Target Express Scripts Has 30%-Plus Upside |
cnn.com/2018/03/26/health/report-medicare-drug-prices-soarin... | Medicare drug prices soar at 10 times rate of inflation, report says |
finance.yahoo.com/m/0bccdc21-6a2b-3019-975d-c3068352a461/pfi... | Pfizer Takes On Gilead, Novartis With New Deal In Cancer Drugs |
axios.com/drug-pricing-contract-express-scripts-d536e8a9-a8a... | The drug pricing contract Express Scripts doesn't want you to see |
fiercepharma.com/pharma/valeant-ceo-papa-s-pay-plummets-as-s... | After 2016's monster bonus--and investor complaints--Valeant CEO's pay crashes from $62M to $5M |
crunchbase.com/organization/pillpack | 5 Year-Old Internet Pharmacy |
cnbc.com/2018/04/02/walmart-buying-pillpack-online-pharmacy-... | Walmart is looking at buying PillPack, an online pharmacy, for under $1 billion |
bloomberg.com/news/articles/2018-04-02/allergan-is-said-to-w... | Allergan Weighs Options for Women's Health Unit |
statnews.com/2018/04/02/medicare-puts-off-drug-pricing-decis... | Medicare puts off decision on lowering drug prices patients pay at the pharmacy |
pharmacist.com/article/cms-lowers-cost-prescription-drugs-me... | CMS lowers the cost of prescription drugs for Medicare beneficiaries |
cnbc.com/2018/04/03/pfizer-and-pg-are-in-talks-on-sale-of-co... | Pfizer in talks with P&G on sale of its consumer business, though they are far apart on price: Sources |
mobile-reuters-com.cdn.ampproject.org/v/s/mobile.reuters.com... | : GSK kicked the tires on Pfizer's OTC business |
statnews.com/pharmalot/2018/04/02/amgen-money-back-guarantee... | Amgen's money-back guarantee for its pricey cholesterol drug may not deliver |
statnews.com/pharmalot/2018/04/02/white-house-opioids-patent... | White House is urged to sidestep patents on opioid overdose treatment |
forbes.com/sites/brucelee/2018/03/31/another-overdose-of-an-... | Death From Loperamide; Intentional Overdose Of Anti-Diarrhea Drug |
telegraph.co.uk/business/2018/04/01/takedas-debts-raise-doub... | Takeda's debts raise doubts over its ability to finance Shire bid |
forbes.com/sites/elliekincaid/2018/03/28/pharma-middlemen-ha... | PBMs: Pharma's Middlemen Have Targets On Their Backs |
endpts.com/fda-dismisses-alkermes-pitch-on-5461-demanding-ne... | FDA dismisses Alkermes' pitch on '5461, demanding new depression trials in a damaging setback |
npr.org/sections/health-shots/2018/04/02/598787768/opioid-us... | Opioid Use Lower In States That Eased Marijuana Laws |
statnews.com/2018/04/02/marijuana-legal-opioid-prescriptions... | Where marijuana is legal, opioid prescriptions fall, studies find |
fiercepharma.com/regulatory/california-transparency-law-forc... | Teva, Valeant price-hike plans trigger warnings under California's new transparency law: report |
washingtonpost.com/amphtml/politics/courts_law/drug-companie... | Drug companies want Supreme Court to take eye-drop dispute |
washingtonpost.com/national/health-science/one-of-americas-m... | One of America's most popular drugs -- first aimed at schizophrenia -- reveals the issues of 'off-label' use |
endpts.com/the-change-up-eli-lillys-new-rd-chief-pledges-to-... | Tired of finishing in last place, Eli Lilly's new R&D chief wants to shake things up |
huffingtonpost.com/entry/opinion-cooley-medications-canada_u... | Americans Need Safer Access To Canadian Online Pharmacies |
marketwatch.com/story/how-a-failed-pfizer-rare-heart-disease... | How a failed Pfizer rare heart-disease drug came back to flatten its rivals |
wsj.com/articles/drug-price-hike-sparks-senate-probe-1522677... | Drug Price Hike Sparks Senate Probe |
edmontonjournal.com/health/health-and-wellness/health-canada... | Canada Health green-lights unpopular prescription-only woman's aphrodisiac |
nasdaq.com/article/impax-reaches-20-mln-deal-to-end-trial-ov... | Impax fined $20 Million in Solodyn pay-to-delay litigation |
fiercepharma.com/legal/allergan-wins-tribal-licensing-reprie... | Allergan's much-maligned tribal licensing deal wins reprieve at appeals court |
thehill.com/policy/healthcare/other/380889-azar-taps-former-... | Azar taps former CVS executive to help lower drug prices |
reason.com/blog/2018/03/27/happy-20th-birthday-to-viagra-the... | Happy 20th Birthday to Viagra, the Accidental Boner Pill That Changed America |
raps.org/news-and-articles/news-articles/2018/3/drug-supply-... | Drug Supply Chain Security: OIG Finds Pharmacies Received Most Tracing Information |
fiercepharma.com/pharma/half-off-sale-at-eli-lilly-as-drug-r... | Half-off sale at Eli Lilly as drug rebating climbs to 51% in 2017 |
reuters.com/article/us-pfizer-study/pfizers-rare-heart-disea... | Pfizer's rare heart disease drug succeeds in late-stage study |
investors.com/news/technology/amgen-sandoz-enbrel-biosimilar... | Novartis Likely Delayed In Launching Copycat Of Amgen Blockbuster |
goinpharma.com/en/sanofi-seeks-to-restore-leadership-diabete... | Sanofi seeks to restore leadership in diabetes treatments |
cnbc.com/2018/03/29/walmart-in-early-stage-acquisition-talks... | Walmart is reportedly in early-stage acquisition talks with Humana |
cnbc.com/2018/03/29/fda-to-consider-updating-health-claims-f... | FDA to consider what 'healthy' means and other claims food companies can make |
wsj.com/articles/takeda-shares-fall-as-investors-queasy-over... | Takeda Shares Fall as Investors Queasy Over Possible Bid for Shire |
forbes.com/sites/brucejapsen/2018/03/29/walgreens-readies-ne... | Walgreens Readies New Store Formats As Amazon And CVS Loom |
cnbc.com/2018/03/28/sage-therapeutics-ceo-well-price-postpar... | Sage Therapeutics CEO: Have to weigh investor returns but will price postpartum drug 'fairly' |
biopharmadive.com/news/spotlight-lilly-bet-pain-drugs-bare-p... | Lilly's bet on pain stands out amid bare pharma pipeline |
bloomberg.com/news/articles/2018-03-29/abbvie-s-ex-humira-sa... | AbbVie Has a Growing Credibility Problem |
onclive.com/web-exclusives/fda-approves-blinatumomab-for-mrd... | FDA Approves Blinatumomab for MRD+ ALL |
epmmagazine.com/news/fda-launches-mobile-app/ | FDA launches mobile app to improve access to information about drugs |
pewtrusts.org/en/research-and-analysis/analysis/2018/03/26/n... | New FDA Web Tool Will Help Doctors Prescribe the Right Antibiotic |
fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResource... | FDA-Recognized Antimicrobial Susceptibility Test Interpretive Criteria |
empr.com/news/diabetes-diagnosis-cost-billions-direct-medica... | Diagnosing Diabetes: How Much Did it Cost in 2017? |
healthline.com/health-news/diabetes-drug-help-obese-people-l... | Can a Diabetes Drug Help Obese People Lose Weight? |
twitter.com/FAIRHealth?ref_src=twsrc%5Etfw | @FAIRHealth |
twitter.com/hashtag/retail?src=hash&ref_src=twsrc%5Etfw | #retail |
twitter.com/hashtag/pharmacy?src=hash&ref_src=twsrc%5Etfw | #pharmacy |
twitter.com/hashtag/clinics?src=hash&ref_src=twsrc%5Etfw | #clinics |
t.co/8ICxFJJfTQ | https://t.co/8ICxFJJfTQ |
t.co/xGySVKQquh | pic.twitter.com/xGySVKQquh |
twitter.com/DrugChannels/status/979381448737284097?ref_src=t... | March 29, 2018 |
biopharmadive.com/news/teva-shire-generic-launch-lialda-comp... | Teva launches generic version of Shire's top-selling internal medicine |
in.reuters.com/article/us-pfizer-study/pfizers-rare-heart-di... | Pfizer's rare heart disease drug succeeds in late-stage study |
endpts.com/assailed-by-fresh-doubts-about-hemlibras-safety-r... | Faced with fresh concerns about Hemlibra's safety, Roche spells out what it knows about 5 deaths |
cnbc.com/2018/03/28/abbott-invests-in-diabetes-care-start-up... | Abbott invests in diabetes care start-up |
bloomberg.com/news/articles/2018-03-28/health-care-m-a-boomi... | Health-Care M&A Balloons in Busiest Start in More Than a Decade |
nytimes.com/2018/03/28/us/politics/david-shulkin-veterans-af... | Veterans Affairs Secretary Is Latest to Go as Trump Shakes Up Cabinet |
reuters.com/article/us-usa-healthcare-gottlieb/fda-working-o... | FDA working on a 'dozen' policies to boost copycat biotech drugs |
bloomberg.com/news/articles/2018-03-28/teva-wins-ruling-toss... | Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict |
endpts.com/shire-shares-rocket-up-after-takeda-says-its-pond... | UPDATED: Shire shares rocket up after Takeda says it's pondering a takeover bid |
forbes.com/sites/johnlamattina/2018/03/28/in-battle-to-cut-d... | In Battle To Cut Drug Prices, Outcome-Based Pricing Carries Big Risks For Biopharma |
politico.com/story/2018/03/25/california-drug-transparency-l... | California's drug transparency law yields early surprises |
forbes.com/sites/matthewherper/2018/03/28/cigna-says-it-redu... | Cigna Says It Reduced Opioid Use By 25% |
wired.com/story/the-yelping-of-the-american-doctor/ | The Yelping of the American Doctor |
biospace.com/article/fda-gives-mylan-s-new-hiv-drug-a-thumbs... | FDA Gives Mylan's New HIV Drug a Thumbs-Up |
nytimes.com/aponline/2018/03/28/health/ap-us-med-selfie-medi... | Selfie Medicine: Phone Apps Push People to Take Their Pills |
raps.org/news-and-articles/news-articles/2018/3/fda-to-usp-b... | FDA to USP: Biological Product Monographs Could Delay Biosimilar Approvals |
xconomy.com/new-york/2018/03/28/edge-to-cut-jobs-as-head-inj... | Edge to Cut Jobs as Head Injury Drug Flops in Phase 3, Shares Tumble |
biopharmadive.com/news/tesaro-posts-mixed-phase-2-data-for-z... | Tesaro posts mixed Phase 2 data for Zejula combo |
biopharmadive.com/news/esperion-bolsters-cholesterol-drug-wi... | Esperion bolsters cholesterol drug with new combo data |
reuters.com/article/us-health-colon-cancer-screening/colon-c... | Colon cancer screening rates vary widely across U.S. |
nytimes.com/2018/03/27/health/opioids-medicare-limits.html | Medicare Is Cracking Down on Opioids. Doctors Fear Pain Patients Will Suffer. |
endpts.com/hemophilia-patients-warned-of-5-deaths-among-pati... | Hemophilia patients warned of 5 deaths among patients taking Roche's big new blockbuster Hemlibra |
marketwatch.com/story/aetna-will-pass-drug-discounts-along-t... | Aetna will pass drug discounts along to some members at the pharmacy counter |
bloomberg.com/news/articles/2018-03-27/novartis-to-sell-stak... | GSK Gets Full Control of Sensodyne Maker for $13 Billion |
drugchannels.net/2018/03/five-takeaways-about-cignas-strateg... | Five Takeaways About Cigna's Strategy for Express Scripts |
reuters.com/article/us-dexcom-fda/fda-approves-dexcoms-gluco... | FDA approves DexCom's glucose monitoring system |
biospace.com/article/fda-accepts-bristol-myers-combo-applica... | FDA Accepts Bristol-Myers Combo Application |
npr.org/sections/health-shots/2018/03/23/593914075/how-socia... | How Social Media Can Reveal Overlooked Drug Reactions |
forbes.com/sites/elliekincaid/2018/03/26/cancers-transformer... | She Was Given Three Years To Live. So She Transformed Cancer Research |
fiercepharma.com/marketing/pharma-social-media-strategies-ma... | Pharma's social media strategies are growing up—and working better, too, report finds |
reuters.com/article/us-novartis-multiple-sclerosis/novartis-... | Novartis touts U.S. filing plans for MS drug as patent losses loom |
washingtonpost.com/news/to-your-health/wp/2018/03/27/testing... | Testing for hepatitis C lags with baby boomers despite high infection rate |
bloomberg.com/news/articles/2018-03-26/novartis-ceo-aims-to-... | Novartis CEO Aims to Double China Sales on Faster Drug Approvals |
cnbc.com/2018/03/27/newly-discovered-organ-may-aid-in-cancer... | Newly discovered organ may aid in cancer diagnosis |
msn.com/en-us/news/politics/a-new-poll-found-that-a-majority... | A new poll found that a majority of Americans support a radical change to the US healthcare system |
youtube.com/watch?v=gBzJGckMYO4 | That's All Folks! |
Внутренние ссылки главной страницы ( 9 ) | |
coreynahman.com/viagra.html | Viagra |
coreynahman.com/FDA_Page.html | Gen Info;Site Dissection |
coreynahman.com/site-map.html | Site Map |
coreynahman.com/practicaladvice.html | Pharmaceutical Sales |
coreynahman.com/diabetesDrugsDatabase.html | Diabetes Drugs |
coreynahman.com/druginfopage.html | Drug Information Databases |
coreynahman.com/Viagra-For-Women.html | - Viagra For Women; Investigative Report |
coreynahman.com/privacypolicy.html | plain English privacy policy |
coreynahman.com/site-mission-statement.html | Site Mission Statement, Intended Audience, Editorial Policy, Advertising Policy |
Domain Name: COREYNAHMAN.COM
Registry Domain ID: 2704621_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2017-12-20T19:26:26Z
Creation Date: 1998-12-09T05:00:00Z
Registrar Registration Expiration Date: 2024-12-08T05:00:00Z
Registrar: NETWORK SOLUTIONS, LLC.
Registrar IANA ID: 2
Reseller:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registry Registrant ID:
Registrant Name: PERFECT PRIVACY, LLC
Registrant Organization:
Registrant Street: 12808 Gran Bay Parkway West
Registrant City: Jacksonville
Registrant State/Province: FL
Registrant Postal Code: 32258
Registrant Country: US
Registrant Phone: +1.5707088780
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: xu3e43kf4ff@networksolutionsprivateregistration.com
Registry Admin ID:
Admin Name: PERFECT PRIVACY, LLC
Admin Organization:
Admin Street: 12808 Gran Bay Parkway West
Admin City: Jacksonville
Admin State/Province: FL
Admin Postal Code: 32258
Admin Country: US
Admin Phone: +1.5707088780
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: xu3e43kf4ff@networksolutionsprivateregistration.com
Registry Tech ID:
Tech Name: PERFECT PRIVACY, LLC
Tech Organization:
Tech Street: 12808 Gran Bay Parkway West
Tech City: Jacksonville
Tech State/Province: FL
Tech Postal Code: 32258
Tech Country: US
Tech Phone: +1.5707088780
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email: xu3e43kf4ff@networksolutionsprivateregistration.com
Name Server: A.NS.INTERLAND.NET
Name Server: B.NS.INTERLAND.NET
Name Server: C.NS.INTERLAND.NET
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
>>> Last update of WHOIS database: 2018-12-28T10:36:27Z <<<
For more information on Whois status codes, please visit https: //www.icann.org/resources/pages/epp-status-codes-2014-06-16-en
This listing is a Network Solutions Private Registration. Mail
correspondence to this address must be sent via USPS Express Mail(TM) or
USPS Certified Mail(R); all other mail will not be processed. Be sure to
include the registrant's domain name in the address.
США - 64.136.20.37
Netzero,INC.
Juno Online Services
HTTP/1.1 200 OK
Date: Thu, 26 Dec 2019 07:12:17 GMT
Server: Apache
Last-Modified: Thu, 05 Apr 2018 22:28:24 GMT
ETag: "5e643fd4-12654-7528d200"
Accept-Ranges: bytes
Content-Length: 75348
Cache-Control: max-age=-54376733
Expires: Thu, 05 Apr 2018 22:33:24 GMT
Vary: Accept-Encoding,User-Agent
Content-Type: text/html
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"